Head-to-head · free
Insulet Corp. vs Roche Holding AG
PODD vs RHHBY — return on capital, cash generation, margins and balance sheet side by side.
PODD
0 / 0
measures where PODD leads
RHHBY
0 / 0
measures where RHHBY leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | PODD · FY2025 | RHHBY |
|---|---|---|
| Revenue | $2.7B | — |
| Net income | $247.1M | — |
| Revenue growth (yearly, multi-year) | 25.3% | — |
| Free cash flow | $377.7M | — |
| Free cash flow margin | 13.9% | — |
| Net cash / (debt) | — | — |
| ROIC | 13.6% | — |
| Return on equity | 18.1% | — |
| Gross margin | 71.6% | — |
| Operating margin | 17.5% | — |
| Net debt / EBITDA | 0.41x | — |
Figures are as reported by each company; latest fiscal year shown.
Where Insulet Corp.'s cash went (FY2025)
- Capital spending
- $191.6M
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free